Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Mobile revolution brings changes to cardiology management
• Darren K. McGuire, MD, MHSc, at forefront of clinical trial evolution
• Biotronik announces FDA approval, launch of three products for patients with heart failure, arrhythmias
• DES system designed for patients with large vessels approved by FDA
• FDA approves line of ICDs, CRT-Ds for patients with heart failure
• Three cardiac resynchronization therapy pacemakers approved to treat patients with heart failure
• 2 decades of stroke
• Cardiology Today’s Next Gen Innovators identify promising areas of CV research
• Discovery of six new genetic risk variants predisposing to CAD Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Calvin W. Roberts, MD; Arlene Campillo, BS; William L. Roberts, MHA, CPA; Brandon A. Roberts, MSc, MD
• ACC, AHA, HFSA release updated guidelines for HF management
• ANGPTL3 loss-of-function mutation may confer lower risk for CAD
• HEART score to assess patients with chest pain underutilized in EDs
• Insurance appeals, denials delay patient access to PCSK9 inhibitors
• Nutrient raising TMAO level linked to platelet hyperresponsiveness, but aspirin mitigates effect
• Patients unaware of statin use report no increase in muscle-related symptoms
• Secondary prevention treatments may benefit patients with MI, nonobstructive coronary arteries
• Unemployment may increase risk for stroke
• USPSTF guidelines on statin therapy result in fewer referrals
• USPSTF recommends routine BP measurements for preeclampsia screening
• Aspirin may not benefit patients with peripheral vascular disease
• Vitamin D supplements fail to prevent CVD
• ADVANCEIII: Long-detection programming beneficial for patients with single-chamber ICDs
• AEIOU: Regardless of interruption during AF ablation, apixaban comparable to warfarin for stroke prevention
• Beta-blockers reduce mortality in HFrEF with sinus rhythm
• EDIFY: Ivabradine fails to improve outcomes in HFpEF
• Effective patient–physician communication produces better outcomes in atherosclerotic CVD
• EWOLUTION: Left atrial appendage closure device safe, effective at 1 year
• Smartwatch heart rate sensor capable of detecting atrial fibrillation
• Transcatheter leadless pacemaker successful in real-world setting
• VIDEO: New NLA president discusses updates to PCSK9 inhibitor recommendations
• An evidence-based look at the CV safety of NSAIDs Carol Heunisch, PharmD, BCPS, BCCP; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: ADVANCEIII
• Trial Scorecard: AIRLESS
• Trial Scorecard: CORONOR
• Trial Scorecard: EDIFY
• Trial Scorecard: ENABLE
• Trial Scorecard: ENDURANCE Supplemental
• Trial Scorecard: PORTRAIT
• Trial Scorecard: RESTORE